018179787

ZURJEDDO

---

January 12, 2020

Trademark Summary

The trademark application ZURJEDDO was filed by Eli Lilly and Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on March 25, 2020, and it was registered by office on July 3, 2020 without any oppositions.

The application was filed in English (Italian was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on September 30, 2020.

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Pharmaceutical preparations namely, pharmaceutical preparations for the treatment, prevention and/or diagnosis of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders
  2. Pharmaceutical preparations for the treatment, prevention and/or diagnosis of cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders
  3. Pharmaceutical preparations for the treatment, prevention and/or diagnosis of headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders
  4. Pharmaceutical preparations for the treatment, prevention and/or diagnosis of lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders
  5. Pharmaceutical preparations for the treatment, prevention and/or diagnosis of neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy and ulcerative colitis
  6. Diagnostic agents and substances for medical purposes
  7. Radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain
  8. Pharmaceutical preparations.